LRRC8D expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.46844775123145E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.37920008747017E-10 |
Normal-vs-Stage2 |
9.54729999946835E-07 |
Normal-vs-Stage3 |
2.64110000536277E-09 |
Normal-vs-Stage4 |
1.15540000011904E-07 |
Stage1-vs-Stage2 |
3.469600E-01 |
Stage1-vs-Stage3 |
2.717200E-01 |
Stage1-vs-Stage4 |
4.991200E-01 |
Stage2-vs-Stage3 |
9.872000E-01 |
Stage2-vs-Stage4 |
8.252600E-01 |
Stage3-vs-Stage4 |
7.869200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.01736413632625E-12 |
Normal-vs-AfricanAmerican |
1.58610000022819E-07 |
Normal-vs-Asian |
3.950400E-01 |
Caucasian-vs-AfricanAmerican |
4.638600E-01 |
Caucasian-vs-Asian |
3.098800E-01 |
AfricanAmerican-vs-Asian |
2.157000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.95377047873535E-12 |
Normal-vs-Female |
1.30339999904194E-08 |
Male-vs-Female |
4.170300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.517000E-03 |
Normal-vs-Age(41-60Yrs) |
9.57278700752795E-12 |
Normal-vs-Age(61-80Yrs) |
1.61169966261809E-10 |
Normal-vs-Age(81-100Yrs) |
1.76151999999874E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.441000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.077000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.066000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.637200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.489200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.595600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.916500E-03 |
Normal-vs-Grade 2 |
2.17359999998834E-08 |
Normal-vs-Grade 3 |
7.50888240474978E-12 |
Normal-vs-Grade 4 |
9.71809965832904E-10 |
Grade 1-vs-Grade 2 |
9.398400E-01 |
Grade 1-vs-Grade 3 |
6.185800E-01 |
Grade 1-vs-Grade 4 |
3.293200E-01 |
Grade 2-vs-Grade 3 |
1.239630E-01 |
Grade 2-vs-Grade 4 |
2.852400E-02 |
Grade 3-vs-Grade 4 |
1.997040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
9.5650000031533E-08 |
Normal-vs-ccB subtype |
7.29729610071672E-11 |
ccA subtype-vs-ccB subtype |
3.360200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.97179955591298E-10 |
Normal-vs-N1 |
3.079000E-01 |
N0-vs-N1 |
2.348200E-01 |
|
|